AR046145A1 - PHARMACEUTICAL COMPOSITION CONTAINING AT LEAST ONE COMPOUND WITH RECEIVER ACTIVITY OF CB1, OR A PROFARMACO, TAUTOMERO OR SALT OF THE SAME, AS A SUITABLE ACTIVE COMPONENT FOR THE TREATMENT AND / OR PROFILAXIS OF DISEASES RELATED TO CB1 RECEPTOR IN YOUTH AND YOUTH PATIENTS TREATMENT AND / - Google Patents
PHARMACEUTICAL COMPOSITION CONTAINING AT LEAST ONE COMPOUND WITH RECEIVER ACTIVITY OF CB1, OR A PROFARMACO, TAUTOMERO OR SALT OF THE SAME, AS A SUITABLE ACTIVE COMPONENT FOR THE TREATMENT AND / OR PROFILAXIS OF DISEASES RELATED TO CB1 RECEPTOR IN YOUTH AND YOUTH PATIENTS TREATMENT AND /Info
- Publication number
- AR046145A1 AR046145A1 ARP040103854A AR046145A1 AR 046145 A1 AR046145 A1 AR 046145A1 AR P040103854 A ARP040103854 A AR P040103854A AR 046145 A1 AR046145 A1 AR 046145A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- youth
- receptor
- salt
- patients
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Uso terapéutico de compuestos con actividad antagonista de receptor de cannabis-1 CB, elegidos del grupo de derivados de 4,5-dihidro-1H-pirazol, derivados de 1H-imidazol, derivados de tiazol y7o derivados de 1H-1,2,4-triazol-3-carboxamida, o un profármaco, tautómero o sal de los mismos, en la preparación de medicamentos para el tratamiento y/o profilaxis de enfermedades relacionadas con receptor de CB, en pacientes juveniles y/o para el tratamiento y/o profilaxis de obesidad inducida por drogas en pacientes juveniles así como adolescentes. Uso de dichos compuestos con actividad de receptor de CB, en combinación con inhibidores de lipasa. Dichos compuestos son particularmente apropiados en combinación con inhibidores de lipasa en la preparación de medicamentos para el tratamiento y/o profilaxis de la obesidad en pacientes adolescentes o juveniles y/o para el tratamiento y/o profilaxis de obesidad inducida por drogas en pacientes juveniles así como adolescentes. Inhibidores de lipasa preferidos son orlistat, panclicinas, ATL-952 y/o lipstatina.Therapeutic use of compounds with cannabis-1 CB receptor antagonist activity, chosen from the group of 4,5-dihydro-1H-pyrazole derivatives, 1H-imidazole derivatives, thiazole derivatives and 7H-1,2,4 derivatives -triazol-3-carboxamide, or a prodrug, tautomer or salt thereof, in the preparation of medicaments for the treatment and / or prophylaxis of diseases related to CB receptor, in juvenile patients and / or for the treatment and / or Drug-induced obesity prophylaxis in juvenile as well as adolescent patients. Use of said compounds with CB receptor activity, in combination with lipase inhibitors. Such compounds are particularly suitable in combination with lipase inhibitors in the preparation of medicaments for the treatment and / or prophylaxis of obesity in adolescent or juvenile patients and / or for the treatment and / or prophylaxis of drug-induced obesity in juvenile patients as well. as teenagers Preferred lipase inhibitors are orlistat, panclicins, ATL-952 and / or lipstatin.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03103967 | 2003-10-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR046145A1 true AR046145A1 (en) | 2005-11-23 |
Family
ID=34924121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040103854 AR046145A1 (en) | 2003-10-27 | 2004-10-22 | PHARMACEUTICAL COMPOSITION CONTAINING AT LEAST ONE COMPOUND WITH RECEIVER ACTIVITY OF CB1, OR A PROFARMACO, TAUTOMERO OR SALT OF THE SAME, AS A SUITABLE ACTIVE COMPONENT FOR THE TREATMENT AND / OR PROFILAXIS OF DISEASES RELATED TO CB1 RECEPTOR IN YOUTH AND YOUTH PATIENTS TREATMENT AND / |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR046145A1 (en) |
| TW (1) | TW200530219A (en) |
-
2004
- 2004-10-22 TW TW93132077A patent/TW200530219A/en unknown
- 2004-10-22 AR ARP040103854 patent/AR046145A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200530219A (en) | 2005-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1109624T1 (en) | Substituted thiophene derivatives as glycogen receptor antagonists, preparations and therapeutic uses | |
| ECSP105253A (en) | DERIVATIVES OF 5-PHENYLTIAZOL AND USE AS INHIBITORS OF PI3 CINASA | |
| AR027548A1 (en) | USEFUL DERIVATIVES OF AMINO PIRAZOL FOR THE TREATMENT OF OBESITY AND OTHER DISORDERS | |
| IS8503A (en) | Azate cyclic heterocycles as cannabinonide receptor antagonists | |
| NO20062689L (en) | Azabicyclic heterocycles as modulators of cannabinoid receptors | |
| DE602005014341D1 (en) | BENZIMIDAZOL SUBSTITUTED THIOPHENE DERIVATIVES ACTING ON IKK3 | |
| DE602006006712D1 (en) | THIAZOLYLPIPERIDINE DERIVATIVES USE AS H3 RECEPTOR MODULATORS | |
| IS8502A (en) | Azate cyclic heterocycles as cannabinoid receptor antagonists | |
| ECSP034640A (en) | DERIVATIVES OF PHENYLETENYL OR PHENYLETINYL AS ANTAGONISTS OF THE GLUTAMATE RECEIVER | |
| UA83862C2 (en) | Thiazole derivatives as cannabinoid receptor modulators | |
| NO20070336L (en) | Indole derivatives as histamine receptor antagonists | |
| ES2337596T3 (en) | ANTIGONISTS OF THE RECEIVER OF GLUCATION, PREPARATION AND THERAPEUTIC USES. | |
| TW200626158A (en) | Naphthaline derivatives | |
| ATE459619T1 (en) | GLUCAGON RECEPTOR ANTAGONISTS, THEIR PREPARATION AND THERAPEUTIC USE | |
| CY1110947T1 (en) | COMBINATION PRODUCT OF AN ANTAGONIST OR AN AGONIST REVERSE OF RECEPTOR H3 OF ISTAMINIS with an anti-psychotic or anti-depressant agent, and its use for preparing a medicament which prevents THE SIDE EFFECTS Psychotropic Drugs | |
| ECSP056202A (en) | DERIVATIVES OF IMIDAZOL AS ANTAGONISTS OF THE GLUTAMATE RECEIVER | |
| WO2005082893A3 (en) | Histamine h3 receptor antagonists, preparation and therapeutic uses | |
| ATE478856T1 (en) | SPIROBENZODIOXOLS AND THEIR USE AS CB1 ANTAGONISTS | |
| MX2007006387A (en) | 3-substituted pyridine derivatives as h3 antagonists. | |
| MX2007007027A (en) | Piperazinyl pyridine derivatives as anti-obesity agents. | |
| ECSP088967A (en) | MUSCARINIC RECEIVER AGONISTS THAT ARE EFFECTIVE IN THE TREATMENT OF PAIN, ALZHEIMER'S DISEASE AND SCHIZOPHRENIA | |
| ECSP088966A (en) | MUSCARINIC RECEIVER AGONISTS THAT ARE EFFECTIVE IN THE TREATMENT OF PAIN, ALZHEIMER'S DISEASE AND SCHIZOPHRENIA | |
| ATE418548T1 (en) | SUBSTITUTED 3-CYANOTHIOPHENE ACETAMIDE AS GLUCAGON RECEPTOR ANTAGONISTS | |
| WO2005060959A8 (en) | Pyrazole derivatives and use thereof as orexin receptor antagonists | |
| ATE507218T1 (en) | BENZODIAZEPINE DERIVATIVES AS ROCK KINASE INHIBITORS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |